ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 170 filers reported holding ENANTA PHARMACEUTICALS INC in Q1 2022. The put-call ratio across all filers is 0.43 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,269,716 | +30.1% | 113,672 | +149.3% | 0.00% | -25.0% |
| Q2 2023 | $975,754 | +54.1% | 45,596 | +191.3% | 0.00% | +33.3% |
| Q1 2023 | $633,048 | -41.8% | 15,654 | -33.1% | 0.00% | -50.0% |
| Q4 2022 | $1,088,382 | -39.5% | 23,396 | -32.6% | 0.01% | -45.5% |
| Q3 2022 | $1,800,000 | +620.0% | 34,699 | +556.6% | 0.01% | +450.0% |
| Q2 2022 | $250,000 | -62.2% | 5,285 | -43.2% | 0.00% | -66.7% |
| Q1 2022 | $662,000 | +4.4% | 9,303 | +9.7% | 0.01% | +20.0% |
| Q4 2021 | $634,000 | +26.8% | 8,479 | +4.7% | 0.01% | -68.8% |
| Q4 2019 | $500,000 | – | 8,096 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 858,811 | $36,156,000 | 10.56% |
| Fairmount Funds Management LLC | 150,433 | $6,333,000 | 2.26% |
| ARMISTICE CAPITAL, LLC | 1,356,000 | $57,088,000 | 1.94% |
| FARALLON CAPITAL MANAGEMENT LLC | 1,775,000 | $74,728,000 | 0.45% |
| Virtus ETF Advisers LLC | 14,321 | $603,000 | 0.25% |
| Granahan Investment Management | 231,071 | $9,728,000 | 0.22% |
| JACOBS LEVY EQUITY MANAGEMENT, INC | 248,320 | $10,454,000 | 0.09% |
| ACADIAN ASSET MANAGEMENT LLC | 467,514 | $19,684,000 | 0.08% |
| VIRTUS ALTERNATIVE INVESTMENT ADVISERS, INC. | 126 | $5,000 | 0.08% |
| AIGEN INVESTMENT MANAGEMENT, LP | 12,854 | $541,000 | 0.07% |